1 Introduction 8
1.1 Industry Definition and Research Scope 8
1.1.1 Industry Definition 8
1.1.2 Research Scope 9
1.2 Research Methodology 12
1.2.1 Overview of Market Research Methodology 12
1.2.2 Market Assumption 13
1.2.3 Secondary Data 13
1.2.4 Primary Data 13
1.2.5 Data Filtration and Model Design 15
1.2.6 Market Size/Share Estimation 16
1.2.7 Research Limitations 17
1.3 Executive Summary 18
2 Market Overview and Dynamics 21
2.1 Market Size and Forecast 21
2.1.1 Impact of COVID-19 on World Economy 23
2.1.2 Impact of COVID-19 on the Market 26
2.2 Major Growth Drivers 28
2.3 Market Restraints and Challenges 31
2.4 Emerging Opportunities and Market Trends 34
2.5 Porter's Fiver Forces Analysis 38
3 Segmentation of Global Market by Vaccine Type 42
3.1 Market Overview by Vaccine Type 42
3.2 Live/Attenuated Vaccines 44
3.3 Inactivated Vaccines 45
3.4 Subunit Vaccines 46
3.5 Toxoid Vaccines 47
3.6 Conjugate Vaccines 48
3.7 Recombinant Vector Vaccines 49
3.8 Other Vaccines 50
4 Segmentation of Global Market by Disease 51
4.1 Market Overview by Disease 51
4.2 Vaccines for Pneumococcal Disease 53
4.3 Vaccines for Poliovirus 54
4.4 Vaccines for Hepatitis 55
4.5 Vaccines for Influenza 56
4.6 Vaccines for Measles, Mumps, and Rubella (MMR) 57
4.7 Vaccines for Varicella 58
4.8 Vaccines for Human Papilloma Virus 59
4.9 Vaccines for COVID-19 60
4.10 Vaccines for Other Diseases 61
5 Segmentation of Global Market by Administration 62
5.1 Market Overview by Administration 62
5.2 Intramuscular Route 64
5.3 Subcutaneous Route 65
5.4 Oral Route 66
5.5 Intravenous Injection 67
5.6 Other Administration Routes 68
6 Segmentation of Global Market by Patient 69
6.1 Market Overview by Patient 69
6.2 Pediatric Vaccines 71
6.3 Adult Vaccines 73
7 Segmentation of Global Market by Region 75
7.1 Geographic Market Overview 2019-2026 75
7.2 North America Market 2019-2026 by Country 79
7.2.1 Overview of North America Market 79
7.2.2 U.S. 82
7.2.3 Canada 87
7.2.4 Mexico 90
7.3 European Market 2019-2026 by Country 93
7.3.1 Overview of European Market 93
7.3.2 UK 96
7.3.3 France 99
7.3.4 Germany 102
7.3.5 Spain 105
7.3.6 Italy 108
7.3.7 Russia 111
7.3.8 Rest of European Market 114
7.4 Asia-Pacific Market 2019-2026 by Country 116
7.4.1 Overview of Asia-Pacific Market 116
7.4.2 China 119
7.4.3 Japan 122
7.4.4 India 126
7.4.5 Australia 129
7.4.6 South Korea 132
7.4.7 Rest of APAC Region 135
7.5 South America Market 2019-2026 by Country 137
7.5.1 Argentina 140
7.5.2 Brazil 143
7.5.3 Columbia 146
7.5.4 Rest of South America Market 149
7.6 MEA Market 2019-2026 by Country 150
7.6.1 UAE 153
7.6.2 Saudi Arabia 156
7.6.3 Egypt 159
7.6.4 Other National Markets 162
8 Competitive Landscape 163
8.1 Overview of Key Vendors 163
8.2 New Product Launch, Partnership, Investment, and M&A 166
8.3 Company Profiles 167
AstraZeneca plc 167
Bavarian Nordic A/S 169
China National Biotec Group Company Ltd. 170
CSL Ltd. 171
Daiichi Sankyo Co. Ltd 172
Emergent BioSolutions Inc. 173
GlaxoSmithKline PLC 174
Johnson & Johnson 175
Merck & Co. 176
Novavax, Inc. 177
Pfizer Inc. 178
Sanofi SA 179
Takeda Pharmaceutical Co. Ltd 180
9 Investing in Global Market: Risk Assessment and Management 181
9.1 Risk Evaluation of Global Market 181
9.2 Critical Success Factors (CSFs) 184
Related Reports and Products 187